Plastic Surgery Doctors in Coral Springs, FL Accepting Medicare

3 Plastic Surgery doctors found. Showing 1 - 3

Dr. Bose Yalamanchi, MD PA Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1134 Wiles Rd, Coral Springs, FL 33076 Phone: 954-344-4555    Fax: 954-840-8254

Dr. Floyd Leigh Phillips Iii, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2855 N University Dr Ste 400, Coral Springs, FL 33065 Phone: 954-344-4344    Fax: 954-344-3781

Dr. David J. Levens, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1725 N University Dr, Suite 440, Coral Springs, FL 33071 Phone: 954-752-1020    Fax: 954-752-0717

News Archive

Revolutionary new neck support collars for patients with Motor Neurone Disease

A revolutionary new device to replace ‘hated' neck support collars for Motor Neurone Disease (MND) patients has been developed.

Study assesses COVID-19 policy differences between GOP- and Democrat-led states

The per-capita rates of new COVID-19 cases and COVID-19 deaths were higher in states with Democrat governors in the first months of the pandemic last year, but became much higher in states with Republican governors by mid-summer and through 2020, possibly reflecting COVID-19 policy differences between GOP- and Democrat-led states, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Medical University of South Carolina.

The Endocrine Society issues Statement of Principles on EDCs and public health protection

In a Statement of Principles unveiled today, The Endocrine Society proposes a streamlined definition for endocrine-disrupting chemicals (EDCs) and offers recommendations that will strengthen the ability of current screening programs to identify EDCs.

Antidepressant and anti-anxiety medications linked to increased risk of cardiovascular events and death

Women with suspected coronary artery disease (CAD) who report taking antidepressant and anti-anxiety medications have an increased risk of cardiovascular events, including heart attacks and strokes, and death compared to women not taking these medications, according to researchers at the Uniformed Services University of the Health Sciences (USU).

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics, today announced clinical results with its investigational new drug, Serdaxin®for the treatment of major depressive disorder.

Read more Medical News

› Verified 5 days ago